Herbal remedy blamed for high cancer rate in Taiwan
Aristolochic acid (AA) is a common ingredient in Asian remedies for weight loss, easing joint pain and improving stomach ailments. AA is also a potent human carcinogen.
According to the latest research, AA can interact with a person’s DNA and form unique biomarkers of exposure, as well as creating signals within tumour-suppressing genes that indicate the carcinogen has been ingested.
Urinary tract- and kidney cancer rates are about four times higher in Taiwan than in Western countries, according to the research published in the Proceedings of the National Academy of Sciences. Previous research has shown than about one-third of the population of Taiwan has taken AA in recent years.
‘It is a rare tumour and Taiwan has the highest incidence of any country in the world,’ said lead author, Arthur Grollman of the Stony Brook University in the United States.
The research was based on data collected from 151 patients with urinary tract cancer, of whom 60% showed specific mutations linked to the herbal remedy. After being ingested, the acid forms a unique kind of lesion in the renal cortex, and also gives rise to a particular mutational signature in the TP53 tumour-suppressing gene, according to the study.
The herb is also known as ‘birthwort’ because it was often given to women during childbirth.
‘This has been used by every culture in the world from the earliest written record,’ said Grollman.
In the 1990s, a group of Belgian women reported sudden late-stage kidney failure after taking a weight-loss drug that contained AA.
Even though many countries have taken steps to warn of the risk, the ingredient is difficult to control and still finds its way into products via the internet, said Grollman, adding that most of the AA products currently being used in Taiwan are made in China.
Source: Sapa; AFP
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Herbal remedy blamed for high cancer rate in Taiwan
by Health-e News, Health-e News
April 18, 2012